Generate joins CooperSurgical, advancing the health of women, babies and families
In November 2021 it was announced that CooperCompanies acquired Generate Life Sciences under its CooperSurgical banner. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics.
Read More
Stem cell therapy: Boy’s umbilical cord blood could help sister with leukaemia
Daily Telegraph: Lisa Mayoh
Read More
Cell Care Joins the Generate Life Sciences Family to Create a Global Platform
Cell Care, Australia’s leading cord blood bank, today announced it has been acquired by Generate Life Sciences (Generate). Generate operates Cord Blood Registry (CBR), North America’s largest cord blood bank and one of the world’s preeminent stem cell R&D organisations.
Read More
Umbilical cord mesenchymal stem cells used for COVID-19 trial
Doctors in Florida say a clinical trial using stem cells from cord tissue has been incredibly successful in treating patients with severe cases of COVID-19. Patients from Jackson Memorial Hospital and the University Miami Tower are involved, with many of them with acute respiratory distress syndrome (ARDS).
Read More
Media Highlights Cord Blood Potential For Cerebral Palsy
The media reports, featuring Professor Iona Novak who is internationally regarded for her ground-breaking research in the treatment of cerebral palsy.
Read More
Ash Pollard chooses to store her baby’s stem cells with Cell Care
Ash Pollard needs no introduction. After announcing her pregnancy earlier in the year, we are excited that Ash has decided to store her baby’s cord blood and tissue with Cell Care. Ash attended a Tummy Talks antenatal class and this is where she heard about cord blood banking. Listen to the discussion between Midwife Cath...
Read More
Covid-19 Cord Blood Trial
Channel 7 News have reported cord blood-derived cells are being used in a world first clinical trial to treat COVID-19. Monash University and Monash Health are undertaking the trial for severe COVID-19 patients who are anticipated to improve within 24 hours of cord blood treatment.
Read More
COVID-19 and Umbilical Cord Tissue
The impact of COVID-19 is being felt worldwide and there is a tremendous amount of research being undertaken to understand this disease, prevent its transmission, and treat those infected. Patients with COVID-19 can present with little to no symptoms, cold or flu like symptoms, or in severe cases, can progress to pneumonia, sometimes leading to death.
Read More
COVID-19 Update
As the potential consequences of the coronavirus (COVID-19) are felt across many aspects of our lives, we’re reaching out to update our client families. We want to anticipate potential questions regarding the impact of the virus on cord blood collection, storage and therapeutic use.
Read More
Have you considered cord blood banking as a gift for your grandchildren?
You’ve nurtured and prepared your children to be happy and healthy adults. Now they’re grown up with children of their own arriving, there’s different, long lasting support you can provide.
Read More
Cord Blood Expansion Technology May Help Patients With Blood Cancers Like Leukaemia
There have been some exciting developments in a clinical trial investigating expanded cord blood for the treatment of blood cancers including leukemia.
Read More
30 Years of Cord Blood Stem Cell Treatments
October 2018 marked 30 years since Matthew Farrow, a 5-year old boy with Fanconi anemia received treatment using his newborn sister’s umbilical cord blood in the world’s first cord blood transplant. Since then, cord blood stem cells have been used...
Read More
Breakthrough cord blood therapy for children with neurological disorders
Children with various brain disorders who have their own or a sibling’s cord blood stored in a family bank may now be able to receive cord blood therapy regardless of whether they qualify for a targeted clinical trial...
Read More
BREAKING NEWS: Placental stem cell research into stroke therapy takes promising step forward
Australian pre-clinical research has established through trials on mice that systematic administration of placental stem cells, after ischaemic stroke, stimulates significant neuroprotection and facilitates brain recovery and repair.
Read More
Children with Hypoplastic Left Heart Syndrome Receive Cord Blood
This collaborative cord blood stem cell research will assist the determination of the safety and feasibility of injections of autologous umbilical cord blood stem cells into the right ventricle of children with Hypoplastic Left Heart Syndrome...
Read More
Promising autism research using cord blood and cord tissue
Autism research using cord blood has been advanced in recent times by studies at Duke University, North Carolina and Shandong Jiaotong Hospital, China. With over 1 in 100 children in Australia diagnosed with autism...
Read More
Advances in cord blood expansion technologies
Cord blood expansion focuses on the ability to expand the number of cells derived from a cord blood collection. An expanded cord blood unit can further boost utility in both current and future medical uses...
Read More
Choosing Between Cord Blood Donation & Family Cord Banking
Prior to your child’s birth, there are a number of important decisions to make, including choosing what to do with their cord blood. There are essentially two stem cell storage options available to expectant parents...
Read More
New Cord Blood Research Shows Improvements in Cerebral Palsy
A Duke University clinical trial has found the use of umbilical cord blood stem cells increases motor function and brain connectivity in children with cerebral palsy (CP).
Read More
Cell Care joins with Insception Biosciences Inc. to Establish Global Platform.
Cell Care, Australia’s largest cord blood & tissue bank has announced it has acquired Insception Lifebank, Canada’s largest private cord blood & tissue bank. The combined entity creates one of the world’s top 10 companies in the sector.
Read More